| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.068 | 0.1 |